Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuanyan Pharmaceutical Port Bioindustry Liaoning Group is a comprehensive life sciences service provider based in the Benxi High-tech Industrial Development Zone, China. The company operates as an integrated CDMO (Contract Development and Manufacturing Organization), offering services that span drug discovery, process development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosages. It plays a central role in the China Pharmaceutical Capital ecosystem, providing infrastructure and technical support to biotech startups and established pharmaceutical firms. Their capabilities include chemical synthesis, fermentation, and advanced formulation technologies, all adhering to international GMP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuanyan Pharmaceutical Port Bioindustry Liaoning Group.